Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?
Patients may not be pregnant or breastfeeding.
The Brocade 3 Study is a research study evaluating an investigational drug for men and women with metastatic or locally advanced breast cancer that is BRCA-associated.
Randomized, Double-blinded, Placebo-controlled Study
The study is open in 240 locations globally, including sites in many states. For information regarding BROCADE3, contact Abbvie Emerging Med at: (844) 893-5525 or by email.
Sites in the United States include: AZ, AK, CA, CT, CO, FL, GA, IL, IA, MD, MA, MI, MS, MO, NE, NJ, NM, NY, NC, OH, OR, PA, TX, VT, WI
International sites include: Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Colombia, Czech Republic, Denmark, Eastonia, Finland, France, Germany, Hungary, Israel, Italy, Korea, Latvia, Lithuania, Mexico, Netherlands, Norway, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Singaport, South Africa, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom